• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

群体蛋白质组学:癌症生物标志物研究的概念、特性及潜力

Population proteomics: the concept, attributes, and potential for cancer biomarker research.

作者信息

Nedelkov Dobrin, Kiernan Urban A, Niederkofler Eric E, Tubbs Kemmons A, Nelson Randall W

机构信息

Intrinsic Bioprobes, Inc., Tempe, Arizona 85281, USA.

出版信息

Mol Cell Proteomics. 2006 Oct;5(10):1811-8. doi: 10.1074/mcp.R600006-MCP200. Epub 2006 May 30.

DOI:10.1074/mcp.R600006-MCP200
PMID:16735302
Abstract

This review outlines the concept of population proteomics and its implication in the discovery and validation of cancer-specific protein modulations. Population proteomics is an applied subdiscipline of proteomics engaging in the investigation of human proteins across and within populations to define and better understand protein diversity. Population proteomics focuses on interrogation of specific proteins from large number of individuals, utilizing top-down, targeted affinity mass spectrometry approaches to probe protein modifications. Deglycosylation, sequence truncations, side-chain residue modifications, and other modifications have been reported for myriad of proteins, yet little is know about their incidence rate in the general population. Such information can be gathered via population proteomics and would greatly aid the biomarker discovery efforts. Discovery of novel protein modifications is also expected from such large scale population proteomics, expanding the protein knowledge database. In regard to cancer protein biomarkers, their validation via population proteomics-based approaches is advantageous as mass spectrometry detection is used both in the discovery and validation process, which is essential for the detection of those structurally modified protein biomarkers.

摘要

本综述概述了群体蛋白质组学的概念及其在癌症特异性蛋白质调控的发现和验证中的意义。群体蛋白质组学是蛋白质组学的一个应用子学科,致力于研究不同人群和人群内部的人类蛋白质,以定义并更好地理解蛋白质多样性。群体蛋白质组学专注于对大量个体的特定蛋白质进行分析,利用自上而下的靶向亲和质谱方法来探究蛋白质修饰。已报道多种蛋白质存在去糖基化、序列截断、侧链残基修饰及其他修饰,但对其在普通人群中的发生率知之甚少。此类信息可通过群体蛋白质组学收集,这将极大地助力生物标志物的发现工作。通过这种大规模群体蛋白质组学,还有望发现新的蛋白质修饰,从而扩充蛋白质知识数据库。对于癌症蛋白质生物标志物而言,基于群体蛋白质组学的方法进行验证具有优势,因为在发现和验证过程中均使用质谱检测,这对于检测那些结构修饰的蛋白质生物标志物至关重要。

相似文献

1
Population proteomics: the concept, attributes, and potential for cancer biomarker research.群体蛋白质组学:癌症生物标志物研究的概念、特性及潜力
Mol Cell Proteomics. 2006 Oct;5(10):1811-8. doi: 10.1074/mcp.R600006-MCP200. Epub 2006 May 30.
2
Population proteomics: addressing protein diversity in humans.
Expert Rev Proteomics. 2005 Jun;2(3):315-24. doi: 10.1586/14789450.2.3.315.
3
Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application.基于质谱的凝胶蛋白质组学在癌症生物标志物发现中的应用:方法与应用。
Theranostics. 2017 Aug 18;7(14):3559-3572. doi: 10.7150/thno.20797. eCollection 2017.
4
Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer.基于定量质谱的蛋白质组学在卵巢癌生物标志物开发中的应用
Molecules. 2021 May 3;26(9):2674. doi: 10.3390/molecules26092674.
5
Targeted proteomics of solid cancers: from quantification of known biomarkers towards reading the digital proteome maps.实体癌的靶向蛋白质组学:从已知生物标志物的定量到解读数字蛋白质组图谱。
Expert Rev Proteomics. 2015;12(6):651-67. doi: 10.1586/14789450.2015.1094381. Epub 2015 Oct 10.
6
Optomechanical devices for deep plasma cancer proteomics.用于深层等离子体癌症蛋白质组学的光机械装置。
Semin Cancer Biol. 2018 Oct;52(Pt 1):26-38. doi: 10.1016/j.semcancer.2017.08.011. Epub 2017 Sep 1.
7
Mass spectrometry-based proteomics in cancer research.基于质谱的蛋白质组学在癌症研究中的应用
Expert Rev Proteomics. 2017 Sep;14(9):725-727. doi: 10.1080/14789450.2017.1365604. Epub 2017 Aug 21.
8
Population proteomics: investigation of protein diversity in human populations.群体蛋白质组学:人类群体中蛋白质多样性的研究。
Proteomics. 2008 Feb;8(4):779-86. doi: 10.1002/pmic.200700501.
9
Targeted proteomics for cancer biomarker verification and validation.靶向蛋白质组学在癌症生物标志物验证和确证中的应用。
Cancer Biomark. 2022;33(4):427-436. doi: 10.3233/CBM-210218.
10
Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.基于质谱的生物标志物发现、验证及确认——蛋白质生物标志物检测的质量保证与控制
Mol Oncol. 2014 Jun;8(4):840-58. doi: 10.1016/j.molonc.2014.03.006. Epub 2014 Mar 20.

引用本文的文献

1
Proteomic profile of saliva collected directly from ducts: a systematic review.直接从导管采集的唾液的蛋白质组学特征:系统评价。
Clin Oral Investig. 2020 Feb;24(2):559-568. doi: 10.1007/s00784-019-03165-8. Epub 2019 Dec 12.
2
Proteomics approach to identify serum biomarkers associated with the progression of diabetes in Korean patients with abdominal obesity.采用蛋白质组学方法鉴定与韩国腹型肥胖糖尿病患者疾病进展相关的血清生物标志物。
PLoS One. 2019 Sep 10;14(9):e0222032. doi: 10.1371/journal.pone.0222032. eCollection 2019.
3
Predicting high-risk endometrioid carcinomas using proteins.
利用蛋白质预测高危子宫内膜样癌。
Oncotarget. 2018 Apr 13;9(28):19704-19715. doi: 10.18632/oncotarget.24803.
4
Protein biomarkers for subtyping breast cancer and implications for future research.用于乳腺癌分型的蛋白质生物标志物及其对未来研究的意义。
Expert Rev Proteomics. 2018 Feb;15(2):131-152. doi: 10.1080/14789450.2018.1421071. Epub 2018 Jan 3.
5
Mass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms.质谱免疫分析在临床重要蛋白质变体表征中的应用
Proteomes. 2016 Mar 17;4(1):13. doi: 10.3390/proteomes4010013.
6
Top-down proteomics in health and disease: challenges and opportunities.自上而下的蛋白质组学在健康和疾病中的应用:挑战与机遇。
Proteomics. 2014 May;14(10):1195-210. doi: 10.1002/pmic.201300432.
7
Analysis of human blood plasma proteome from ten healthy volunteers from Indian population.对来自印度人群的十名健康志愿者的人体血浆蛋白质组进行分析。
PLoS One. 2013 Aug 20;8(8):e72584. doi: 10.1371/journal.pone.0072584. eCollection 2013.
8
Serum peptidome variations in a healthy population: reference to identify cancer-specific peptides.健康人群血清肽组学变化:寻找癌症特异性肽的参考。
PLoS One. 2013 May 8;8(5):e63724. doi: 10.1371/journal.pone.0063724. Print 2013.
9
Mass spectrometry for translational proteomics: progress and clinical implications.用于转化蛋白质组学的质谱分析:进展与临床意义
Genome Med. 2012 Aug 31;4(8):63. doi: 10.1186/gm364. eCollection 2012.
10
Different expression of S100A8 in malignant and benign gallbladder diseases.S100A8 在胆囊良恶性疾病中的不同表达。
Dig Dis Sci. 2013 Jan;58(1):150-62. doi: 10.1007/s10620-012-2307-0. Epub 2012 Jul 18.